BML Investment Partners, L.P. - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for PMV Pharmaceuticals, Inc. (PMVP)

Filing Manager: BML Investment Partners, L.P.
Reporting Manager: BML Investment Partners, L.P.
Security: PMV Pharmaceuticals, Inc. Common Stock, $0.00001 par value per share
Symbol: PMVP
Shares outstanding: 51.7M shares
Disclosed Ownership: 3.47M shares
Ownership: 6.7%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 10:15 AM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BML Investment Partners, L.P.	6.7%	3.47M	0	3.47M	Braden M Leonard	BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member